{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210602",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "67681",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/761163Orig1s001ltr.pdf",
              "date": "20210603",
              "type": "Letter"
            },
            {
              "id": "67688",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761163s001lbl.pdf",
              "date": "20210603",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20200731",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "64162",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761163s000lbl.pdf",
              "date": "20200731",
              "type": "Label"
            },
            {
              "id": "64178",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/761163Orig1s000ltr.pdf",
              "date": "20200803",
              "type": "Letter"
            },
            {
              "id": "64439",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/761163Orig1s000TOC.html",
              "date": "20200827",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "13",
          "submission_status": "AP",
          "submission_status_date": "20250618",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "82614",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761163s013lbl.pdf",
              "date": "20250620",
              "type": "Label"
            },
            {
              "id": "82626",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761163Orig1s013ltr.pdf",
              "date": "20250620",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "BLA761163",
      "sponsor_name": "MORPHOSYS US INC",
      "openfda": {
        "application_number": [
          "BLA761163"
        ],
        "brand_name": [
          "MONJUVI"
        ],
        "generic_name": [
          "TAFASITAMAB-CXIX"
        ],
        "manufacturer_name": [
          "Incyte Corporation"
        ],
        "product_ndc": [
          "73535-208",
          "50881-013"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "TAFASITAMAB"
        ],
        "rxcui": [
          "2387338",
          "2387343"
        ],
        "spl_id": [
          "49d73fc8-03e2-8b9c-e063-6294a90a3a97",
          "a70f85e0-c22b-419a-9be2-51f575932633"
        ],
        "spl_set_id": [
          "ec13ac6b-bfde-4e84-907a-83bd69584d95",
          "9e0a220b-517f-4c86-b581-ffbab493fb58"
        ],
        "package_ndc": [
          "73535-208-01",
          "50881-013-03"
        ],
        "unii": [
          "QQA9MLH692"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "MONJUVI",
          "active_ingredients": [
            {
              "name": "TAFASITAMAB-CXIX",
              "strength": "12MG/KG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SOLUTION",
          "route": "INTRAVENOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}